New At-Home Test Aids In Cancer Screening
There’s encouraging news for the millions of Americans at risk for colon most cancers. A new, easy-to-use fecal occult blood test (FOBT) is available for at-home screening and is designed specifically to detect colon cancer at its earliest stages.
Hemoccult ICT is a brand new, safe and affordable FOBT screening option for colon cancer-the second leading trigger of cancer-related death within the United States. Despite its high incidence, colon cancer is a highly treatable cancer malignancy, with a 90 % survival rate when detected early. Unfortunately, only half of the much more than 80 million Americans over age 50 have been screened for colon most cancers.
The American Cancer malignancy Society recommends annual screening having a FOBT for both men and women beginning at age 50. Annual colon melanoma screening with FOBT has been proven to decrease mortality by 33 percent when compared with no screening. Simply because colon cancer malignancy can take 3 to 10 many years or longer to develop within the average patient, it’s crucial to begin screening prior to developing symptoms.
FOBT vs. Colonoscopy
For years colonoscopy has been the most well-known test in colon melanoma screening. Whilst widely regarded as the gold standard, colonoscopy does have some drawbacks:
Colonoscopy costs between $300 and $1,000, and although covered by insurance for many, millions of Americans lack health insurance.
Standard colonoscopy is usually overwhelming for some people because of the fact that the procedure is typically done under sedation, and since patients are required to follow a special diet and take a very strong laxative before the exam.
Unlike other offered FOBTs, the new Hemoccult ICT has no drug or dietary restrictions-allowing people to begin testing at their convenience. If a test comes back positive, a follow-up colonoscopy typically is recommended.
You can find more information about mesothelioma cancer law, asbestos lung disease, and papillary mesothelioma
